trimethoprim sulfamethizole has been researched along with linezolid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariza, J; Cabellos, C; El Haj, C; Fontova, P; Gómez-Junyent, J; Lloberas, N; Murillo, O; Ribera, A; Tubau, F | 1 |
| Asari, S; Fukuyama, M; Hata, A; Hata, D; Iki, Y; Watanabe, K; Yoshioka, T | 1 |
2 other study(ies) available for trimethoprim sulfamethizole and linezolid
| Article | Year |
|---|---|
Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Drug Combinations; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rifampin; Sulfamethizole; Trimethoprim | 2018 |
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Bacteremia; Clindamycin; Conservative Treatment; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; Heart Septal Defects, Ventricular; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pulmonary Artery; Radiography; Rifampin; Staphylococcal Infections; Sulfamethizole; Trimethoprim | 2019 |